US Stock MarketDetailed Quotes

VKTX Viking Therapeutics

Watchlist

25.355
-2.605-9.32%

Trading Mar 11 11:19 ET

2.85BMarket Cap-25.10P/E (TTM)

Viking Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Viking Therapeutics Q4 2024 Earnings Date

Currency：USDFeb 5, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
EPS	-0.27	-0.32	-0.05
Miss Est.	-9.68%	-28.00%	-16.75%
Net Income	--	-35.42M	--
		-43.94%

Analyst Rating

Strong Buy

Mar 11, 2025

Viking Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 0.000	--
--	2025/Q1	-- / 0.000	--
Feb 5, 2025	2024/Q4	0.000 / 0.000	--
Oct 23, 2024	2024/Q3	0.000 / 0.000	--
Jul 24, 2024	2024/Q2	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 0.000--

--2025/Q1-- / 0.000--

Feb 5, 20252024/Q40.000 / 0.000--

Oct 23, 20242024/Q30.000 / 0.000--

Jul 24, 20242024/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Viking Therapeutics Earnings Reports

Viking Therapeutics | 10-K: FY2024 Annual Report

Feb 26 16:37 ET

Viking Therapeutics | 8-K: Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update

Feb 5 16:13 ET

Viking Therapeutics | 10-Q: Q3 2024 Earnings Report

Oct 23, 2024 17:05 ET

Viking Therapeutics | 8-K: Viking Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Oct 23, 2024 16:11 ET